Faculty Profile

  • Shannon Miller, MD, FASAM, DFAPA, CTTS
  • Professor of Clinical Psychiatry
    Program Dir., Addiction Medicine Research Fellowship
    Co-Program Dir., Addiction Psychiatry Fellowship
    Director, Education and Training Branch, CinARTEC
    Associate Director, CinARTEC
  • Clinical Location:
    Veterans Affairs Medical Center, Cincinnati
    3200 Vine Street, B724
    Cincinnati, OH 45220
  • Phone: (513) 861-3100, ext. 4870
  • Email: Shannon.miller@va.gov

    Research/Clinical Interests:

  • Dr. Miller is Board Certified in both Psychiatry and Addiction Medicine, and is also a Certified Tobacco Treatment Specialist and Certified in Buprenorphine. He works for both the VA and the medical school. Dr. Miller serves as a Founding Co-Editor for Journal of Addiction Medicine. He is also a Co-Editor of the official textbook for the American Society of Addiction Medicine: Principles of Addiction Medicine. He has authored approximately 45 peer-reviewed articles, books, book chapters, abstracts, and technical reports. Dr Miller has worked clinically in most every addiction subspecialty, designed and led the Department of Defense’s Tri-Service Addiction Recovery Center, led the DoD in developing the first DoD-VA Clinical Practice Guidelines for Substance Use Disorders, and published his own original research on addiction.

    Education/Credentials:

  • Residency: Wright Patterson USAF Medical Center/Wright State University
  • Bachelors of Science: Otterbein College
  • Medical Degree: The Ohio State University College of Medicine
  • Professional Military Education: Air Command and Staff College

Peer Reviewed Publications (in chronological order):

  • Miller SC, Backtash S, Webb T, Whitehead C, Wells TS, Gore R. (2013). (In Press). Risk for addiction-related disorders following mild traumatic brain injury among a large cohort of U.S. active duty Airmen . American Journal of Psychiatry.
  • Hermes, E. D. A., Wells, T. S., Smith, B., Boyko, E. J., Gackstetter, G. G., Miller, S. C., & Smith, T. C. (2012). Smokeless tobacco use related to military deployment, cigarettes and mental health symptoms in a large, prospective cohort study among US service members. . Addiction (Abingdon, England) , 107 (5) , 983-94.
  • Wells, T. S., Miller, S. C., Adler, A. B., Engel, C. C., Smith, T. C., & Fairbank, J. A. (2011). Mental health impact of the Iraq and Afghanistan conflicts: a review of US research, service provision, and programmatic responses. . International Review of Psychiatry (Abingdon, England) , 23 (2) , 144-52.
  • Miller, Shannon C (2011). Dextromethorphan to dextrorphan: a pathway towards abuse liability. . Human Psychopharmacology , 26 (1) , 89-90; author reply .
  • Miller, Shannon C (2007). Mnemonic to aid in recalling the core (A, B, C, D, E) DSM-IV-TR criteria. . Military Medicine , 172 (5) , vi-vii.
  • Koob, G. F., Miller, S. C., & Wunsch, M. J. (2007). Inaugural Issue of the Journal of Addiction Medicine. . Journal of Addiction Medicine , 1 (1) , 1.
  • Miller, Shannon C (2006). Language and addiction. . The American Journal of Psychiatry , 163 (11) , 2015; author reply 2.
  • Miller, Shannon C (2005). Dextromethorphan psychosis, dependence and physical withdrawal. . Addiction Biology , 10 (4) , 325-7.
  • Miller, Shannon C (2005). Psychiatric effects of ephedra: addiction. . The American Journal of Psychiatry , 162 (11) , 2198.
  • Sumitra, L. M., & Miller, S. C. (2005). Pathologic gambling disorder. How to help patients curb risky behavior when the future is at stake. . Postgraduate Medicine , 118 (1) , 31-7.
  • Miller, Shannon C (2005). Coricidin HBP cough and cold addiction. . Journal of the American Academy of Child and Adolescent Psychiatry , 44 (6) , 509-10.
  • Bobo WV, Miller SC, Martin BD. (2005). The abuse liability of dextromethorphan among adolescents: a review . Journal of Child and Adolescent Substance Abuse , 14 (4) , 55-75.
  • Bobo, W. V., & Miller, S. C. (2002). Ketamine as a preferred substance of abuse. . The American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions , 11 (4) , 332-4.
  • Bobo, W. V., & Miller, S. C. (2001). Complicated dual diagnosis: a case for physician involvement in addictions treatment. . International Journal of Psychiatry in Medicine , 31 (2) , 233-5.
  • Miller SC (12-2005). (In Press). Treatment of dextromethorphan dependence with naltrexone . Addictive Disorders and Their Treatment , 4 (4) , 145-148.
  • Miller SC (09-1996). (In Press). Methylphenidate for clozapine sedation . American Journal of Psychiatry , 153 (9) , 1231-1232.
  • Miller SC, Frankowski D (08-2012). Prescription opioid use disorder: a complex clinical challenge. Understanding patients’ aberrant medication-taking behaviors can greatly aid treatment. . Current Psychiatry , 11 (8) , 15-21.
  • Miller SC (07-2002). (In Press). Self Assessment in Psychiatry: Substance dependence - review questions . Hospital Physician , 29-30.
  • Miller SC (06-2011). (In Press). Alcohol Use Disorders: Comorbidity, Cognition, and Pharmacotherapies . Psychiatric Times , 28 (6) , 36-38.
  • Miller SC (05-2004). (In Press). Nicotine Use Disorders. In: Psychiatry board review manual. . Hospital Physician , 8 (2) , 1-11.
  • Bobo WV, Miller SC, Smith CJ (05-2002). (In Press). Possible physiologic dependence on dextromethorphan . EWestern Journal of Medicine , 176 (5) .
  • Miller SC, Brown J (05-2002). (In Press). Alcohol use disorders. In: Psychiatry board review manual . Hospital Physician , 6 (2) , 2-12.
  • Miller SC (04-2004). (In Press). Ephedra and FDA . Psychiatric News , 39 (7) , 66-76.
  • Miller SC, Fernandez L, Soria R. (03-2011). (In Press). Pregnancy and opioid use disorders . Current Psychiatry , 10 (3) , 34-45.
  • Miller SC (02-2004). (In Press). Safety concerns regarding ephedrine-type alkaloid-containing dietary supplements . Military Medicine , 169 (2) , 87-93.
  • Miller SC (02-2002). (In Press). Raves and Club Drugs. In: Psychiatry board review manual . Hospital Physician , 7 (1) , 1-12.
  • Miller SC (02-1997). (In Press). Doxycycline-induced lithium toxicity . Journal of Clinical Psychopharmacology , 17 (1) , 54-55.
  • Miller, S. C., & Waite, C. Ephedrine-type alkaloid-containing dietary supplements and substance dependence. . Psychosomatics , 44 (6) , 508-11.
Faculty Member
More Information

Department of Psychiatry and Behavioral Neuroscience

Mailing Address:
PO Box 670559
Cincinnati, OH 45267-0559

Office Location:
Stetson Building
260 Stetson Street
Suite 3200
Cincinnati, OH 45219

Phone: (513) 558-7700
Email: donna.niemeier@uc.edu